Mar
13

WCRI – California’s Work Comp Medical Dispute Resolution

Alex Swedlow, a certified rock star in the world of work comp analytics, held forth on medical dispute resolution as it exists in California.

MDR covers conflicts around the cost, utilization, and “standard of care”, these are evaluated against regulations, guidelines, fee schedules, and refereed by a judge, peer review doc, or some panel of designated experts.

California bill SB 863’s impacts were addressed, and include the following:

  • 3 million liens processed over ten years, but the re-enactment of a fee to file liens in 2013 has cut lien filing fee by over 80%
  • 90% of 2011-2012 liens came from a ten-mile radius in LA – but only 25% of WC claims
  • change to reimbursement for ASCs dropped 28% after a 31% drop in the relevant fee schedule

Now on to the most fun part of 863 – the Independent Medical Review (IMR) “program”.  As Alex said, “boy has IMR been proven popular.”

Volume is 12x the expected volume and runs above 12,000 per MONTH.

Just under 50% of all medical management fees are from UR.

Among the cases that go to elevated UR, about 43% are for pharmacy, most for opioids and compound drugs.  A third of IMR decisions are also for pharmacy.  There’s a lot of misunderstanding about how many medical requests are handled internally vs done by an outside physician reviewer.

Just under 6 percent of all treatment requests were denied or modified before getting to IMR.  4.7% of all treatment requests are denied at the IMR stage.

Less than one in 20 treatment requests are ultimately denied via IMR.

75% approved internally, 18% are approved by elevated review; 4.7% are ultimately denied by the IMR process.

Less than one in 20 treatment requests are ultimately denied via IMR.

CWCI’s next step is to look into how a pharmacy formulary would affect pharmacy spend and scripts; looks like it would dramatically reduce the use of opioids, brand drugs, and compounds.

Stay tuned and check their website for updates on CWCI research.

 


Mar
13

The Affordable Care Act and Work Comp – WCRI’s view

WCRI’s Thursday morning begins with a series of presentations and discussions on the impact of PPACA/Obamacare on workers’ comp.

According to WC Executive Director Rick Victor, “Few pieces of legislation have the potential to affect people both financially and personally as the ACA. ”

(Note – my sense is there’s way too much attribution of normal market changes -positive and negative – to ACA, more on that later)

Rick went on to provide a framework for understanding ACA with specific attention to individual states.  Among the key issues

Will expansion of care lead to:

Shortages of providers who treat injured workers, which may lead to longer disability and higher costs – Victor opined that in states where Medicaid expands shortages will be greater than in non-expansion states. Similarly in states with low health status and/or an older population. As an economist, Victor noted that prices might rise and that will reduce shortages – in this case, payers will pay providers above the fee schedule to get access to care.  There’s a precedent for this in Canada, where providers in Ontario treating work comp patients get paid more than when they treat non-occ patients.  This happens in Massachusetts today as well…

That said, WC ALREADY pays more for specialty care than Medicare or Medicaid or group health in almost all states, so additional payments are likely not necessary. Given a multitude of factors, WCRI predicts the states that will have primary care shortages are:

  • California
  • Florida
  • Louisiana
  • Texas
  • New Mexico
  • Nevada
  • Mississippi

I’d note that most of these are states that – at present – aren’t expanding Medicaid.  If – or more likely when – they decide that Medicaid expansion is a good thing, the predicted provider shortage may get worse.

Healthier employees – The data suggests folks with insurance are healthier than those that are not insured.

Victor doesn’t seem to think ACA will reduce unnecessary care for injured workers. Notably, he didn’t give a time frame for that statement; I firmly believe the work done by PCORI WILL have a dramatic effect on the care that’s delivered to, say, patients with back pain.  That’s going to take time – years, not months, but it will have a big impact.

Lots of discussion of the impact of PPACA on cost shifting – and a wealth of data Rick presented that indicated providers find creative ways to upcode, shift procedure mix, or otherwise find ways to increase revenues in the face of price controls or other regulatory attempts to restrain costs.

My research indicates cost-shifting is a complicated issue.

There’s been a good bit of discussion – some on Mark Walls’ LinkedIn group, on the potential for PPACA to influence claiming behavior.  The net is, I just haven’t seen any credible research that indicates PPACA will lead to more claims.  I’ve discussed this in detail here.

Finally, be careful to NOT attribute anything and everything, good and bad to ACA. A lot of things were occurring before ACA, including provider consolidation, more and higher deductibles, rising costs.

Will ACA accelerate, decelerate or change these trends?  It is impossible to separate out ACA’s effect from that of other factors.

 


Mar
12

WCRI – impact of reform in Illinois

Rebecca Yang analyzed the impact of the 2011 30% fee schedule reduction on prices paid for professional services in IL. Here are the highlights…

  • WC prices paid (not billed, or Fed Schedule) for office visits were 18% lower than group health and 15% below Medicare.
  • Costs for office visits went from 20% above the study state average to 20% below that average after reform.
  • Surgery was a VERY different story; arthroscopic knee surgery costs were 166% higher than group health and 380%+/- above Medicare.
  • Actual prices paid dropped after the reduction, but by 24%, not 30%.  this was likely due to negotiations between the providers and network operators.  In addition, some providers dropped out of networks, eliminating any discount below FS.
  • It appears utilization may have increased, off-setting a third to a half of the impact of price reduction.

Mar
12

WCRI – the effect of WC reform in Texas

Carol Telles spoke briefly on what other states can learn from Texas’ recent reforms – designed to address medical utilization by introducing medical management tools, and reducing utilization. These tools actually added some cost, so the cost:benefit of the reforms have to be considered.

Relative to 14 other states, medical cost per claim over a 15 year period declined from highest among the other states to a position in the bottom third.

A big driver was a large decrease in utilization of non-facility care, which actually dropped by about 30% over the study period.  All other states costs increased, some by 70%.

There were a wide array of changes over a couple different reform periods including broadening the use of UR, implementing health care networks, increasing the prices for medical services, adoption of evidence-based medical guidelines, pre-cert for PT/OT, and a closed formulary for medications.  Most of the effects of these changes weren’t observed until 2011 or 2012, with the formulary’s impact delayed even further.

A few highlights specific to the impact on chiropractic

  • chiro utilization dropped 8.5%; % of claims with chiro dropped 60 percent.
  • the percentage of medical payments for chiro decreased from 10% to 3.5%
  • however, chiros are utilized more in Texas than in any study state except California

Re medical cost containment expenses, costs per claim went up about 40% and have stayed there since the reforms were fully implemented.  These expenses were a third higher than the average study state.

What does this mean for you?

Overall, adding medical management services and their attendant costs appears to be related to reducing medical costs.


Mar
12

WCRI – health reform explained

Today starts off with a discussion of the impact of health care reform on the health care system – there’s another talk tomorrow morning on the impact of ACA; here’s the first of a nine part series I penned last summer…will be interesting to see the panelists’ views.

The first presentation was by MIT’s Dr Jonathan Gruber on health care reform.  Gruber noted that a government-run program is never going to happen, but each time we tried to do this in the past and failed, a chunk of the underserved got some form of relief – Medicaid, Medicare, Part D, S-CHIP, etc.

RomneyCare, seen by many as the basis of PPACA, is a combination of left- and right-favored ideas, including community rating reforms, an individual mandate, and subsidies for those who couldn’t afford insurance on their own.  This went into place in 2006.

The uninisurance rate in Mass. is now 3% (compared to the national rate of about 16%), premiums in the individual market fell by about 50%, and premium trend rates for small employers have been flat for the last couple of years.  However, Mass’ reform was subsidized to the tune of a half-billion dollars.  This too has become part of the basis for PPACA, along with the individual mandate, subsidies for low-income families and expanded Medicaid, and rating reforms.

Lots of nonsense has been dumped on the ACA – the death panels being only one of the most blatantly false.  Gruber highlighted the impossibility due to political issues  – there were just too many forces – political, industry, lobbyists – blocking meaningful cost reduction.  There are, however, five cost control mechanisms.

  1. Cap the taxable benefit of employee health benefits – currently the tax-free status of benefits reduces taxes by $250 billion. The “Cadillac plan” tax cap is intended to address this, albeit in a bass-ackwards way; this will reduce costs by not by much.
  2. Health insurance exchanges – introduced more competition and lowered cost of sale. (in my view the leveling of the playing field coupled with universal coverage will force health plans to compete on the basis of outcomes and cost – and this is going to have a very large, and very positive, effect on long-term cost inflation)
  3. IPAB – independent payment advisory board – which can affect Medicare health reimbursement by forcing Congress to save money or agree to use IPAB’s recommendations.
  4. Research on Comparative Effectiveness
  5. ACO and other experiments; medical homes, bundled payments, and other mechanisms aimed at coordinating care and reducing cost especially for chronic conditions.

In response to a question about freedom, Gruber noted that there are more health plans available now thru the exchanges than there were prior to reform.

Insurance prices for exchange plans for 2014 were about 15% below predictions, however this pricing was more of a guess than an actuarial projection based on past data.  We will know much more at this time next year when the 2015 rates are in place.

I loved Gruber’s characterization of states’ failure to expand Medicaid as political malpractice…

 


Mar
11

We are so screwed.

That’s the conclusion I’ve reached partway thru a quick-and-dirty survey of a handful of savvy, connected brokers.

The people who buy workers’ comp insurance and or claims and/or medical management are, mostly, clueless.  

They succumb to spreadsheets when comparing TPAs.  Because they have no idea how to separate out the good ones, they go for the cheapest per-claim fee, then are surprised when their ALAE costs are thru the roof.  But hey, that’s “claim-related” so they’re safe.

They bitch at their insurer when their claims costs go up, but won’t direct to good docs, or educate their employees before injuries, or hold management accountable.

They think bigger networks are better networks, that deeper discounts deliver big savings, that case management is the “state of the art.”  Many are quite ignorant of evidence-based medicine – which to my mind is the ONLY way we’re ever going to deliver quality care at reasonable prices.

Providers who pitch outcomes and return to work get some traction with a few of the bigger employers, but nowhere near enough to change the managed care business model.

To be fair, some large employers – think Lowe’s, Costco, Safeway – are doing really great stuff, and I’m sure there are lots of others who are innovating and improving and demanding performance.

The only thing that’s protecting these “buyers” is the up-and-down insurance cycle, a driver that has a disproportionate effect on the price and availability of work comp insurance and claims services.  Those that think they are safe may want to consider what’s coming.  PPACA has and will dramatically affect provider behavior, provider access, and the type and quantity of care delivered.

What does this mean for you?

To paraphrase HL Mencken, you get the work comp results you deserve, and you deserve to get them good and hard.


Mar
10

Friday’s (delayed) catch-up and fast facts

Apologies all – too much work last week and not enough time to get this out.

Here’s what I missed reporting last week.

WCRI’s annual meeting is starting Wednesday – there’s a ton on the agenda, attendance looks high, and I’ll be “live blogging” throughout.

There’s increasing evidence that health care cost trends have continued to moderate.  However, people – employees, individuals, moms and dads – are seeing higher cost-sharing and contributing more to their premiums.  Thus the “good news” is mainly “good” for policy wonks and not for real people.

On the Obamacare issue, a poll released Friday indicated 55 percent of the currently-uninsured respondents will get coverage rather than pay a fine. The same poll indicated the uninsuranace rate has decreased 1.2 points since the end of 2013.

Meanwhile, those zany, madcap House Republicans are at it again! Yes, they are trying to hold up O-care, this time by tying a fix to the Medicare physician reimbursement rate to delaying the mandate for a couple-or-ten years.  What will they think of next?

In the wild world of work comp, the big news last week was – there was only one private equity deal! Fairpay Solutions was sold by Riverside to Mitchell International in a transaction that sources indicated made the Riverside folks happy but not ecstatic.

That’s it for last week.  Gotta save up my pixels for the forthcoming blog-o-thon aka WCRI.

 

 


Mar
6

The revenge of the nerds

It’s about understanding medical care, cost drivers, and components thereof.

Several years ago (ok, more like ten) I was in a client CEO’s office discussing medical care cost drivers, competitors, and possible differentiation strategies.  He stepped out for a few minutes to take a call, and, finding myself with nothing to do, I pulled out the latest Health Affairs to catch up on the latest and greatest in health policy research.

Upon this august gentleman’s return to his office, he asked me if I actually read Health Affair. When I said I did, he said something to the effect of “no one reads that, they just carry it around to look smart.”

And therein lies the problem.

And no, it’s not that I don’t need all the help I can get to look smart.

It is a lack of attention to the underlying drivers, influencers, issues.  It is a failure to think about how Medicare’s physician reimbursement affects commercial rates, how Medicaid enrollment drives provider behavior, how Part D enrollment influences drug pricing, how the lack of coverage among certain populations increases facility costs to commercially-insureds, how low adoption of evidence-based medicine makes for poor outcomes, how productivity is affected by insurance coverage status, how payment reform will affect workers’ compensation medical expense ratios.

There’s also a predilection on the part of some to ignore, or more commonly discount, information that runs counter to their worldview.  I see this all the time with workers’ comp execs when discussing Obamacare; they allow their political blinders to affect their business decisions.

There is so much happening in health care delivery and financing and reimbursement and evaluation and coverage that no one can possibly keep up.

What does this mean for you?

The ones who take the time to read and listen objectively, to think about import and impact are going to be more prepared, more aware, and better equipped than those that, for ideological or other reasons, have tunnel vision.

And thus more successful.

 


Mar
5

Obamacare’s success is NOT about enrollment

At least not ONLY about enrollment.

What’s missing from the reporting on and discussions about how many and who and where they signed up for health insurance is a much more important issue – what are the health plans doing to improve health and control cost?

You wouldn’t know that from the press or pundits.

The are fighting the proverbial last war, and are not thinking about what it will take to succeed in this one. Amidst all the back-and-forth about young invincibles and risk corridors and subsidies is this reality; the basis for health plans’ financial success has changed – dramatically.

Health plans will no longer succeed by underwriting; that’s dead.  Yes, pricing is critical, but it can’t be used to drive demographics and enrollment, and neither can benefit design.

These tools – benefit design and underwriting – had been the fundamental business drivers for decades.  Now, they no longer exist.

They have been replaced by population health management.

Going forward, health plans’ success will be driven by much-improved, streamlined, integrated health care delivery systems focusing on population health management.

This means identifying those members with chronic health conditions and reaching out – assertively and proactively – to those members.  It means keeping them healthy; the annual cost of an asthmatic that has an acute episode is 20x more than one who doesn’t. Hypertension, diabetes, depression, COPD are all major contributors to health costs, and those health plans that get their members to higher health status will win.

They will have lower total medical costs, and will be able to offer lower premiums, which will drive more enrollment, including enrollment of younger, healthier (that means cheaper) members.

The “how” to do this is incredibly complex, requiring multiple stakeholders to completely change their thinking and success criteria and financial orientation.  To wit:

  • Docs will no longer be motivated to admit/treat/prescribe, but rather to work with patients to get those patients to “do the right thing”
  • Hospitals will want fewer transplants/surgeries/ER admits
  • Medical people will run insurers and health plans
  • In some markets, health plans all become appendages of delivery systems, while the big national players will continue their efforts to partner with local health care delivery systems.
  • Expect much faster and deeper adoption of evidence-based medical guidelines as health plans and their provider partners rely on science to drive improved outcomes.
  • Some smart health plans may actually figure out how to market themselves.  Seriously, it is possible!  Yep, after many, many years of underinvesting in marketing, branding, positioning, health plans are going to spend tens of millions in an effort to brand themselves and achieve “mind share” among consumers.
  • Employer involvement in arranging for employee health benefits will diminish – a lot.

This is already happening – it isn’t pretty, there are lots of starts, stops, and dead-ends, plans will fail and providers go belly-up, but the market will determine the winners. Notably, this wouldn’t have happened without guaranteed enrollment and pre-set benefit plans.

What does this mean for you?

The current flattening of health care trend will continue due to this transformation.

With clear boundaries set by Obamacare, health plans will succeed – or not – based on their ability to do what they should have been doing all along – deliver the best outcomes for the lowest cost.